{"organizations": [], "uuid": "f9c0cf4336962770c882bee05965ed1e8df796ad", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "", "site_section": "http://www.reuters.com/finance/personal-finance", "section_title": "Wealth, Personal Finance &amp; Money | Reuters.com", "url": "http://www.reuters.com/article/2015/07/27/idUSL5N1072L020150727", "country": "US", "title": "BRIEF-Teva says Allergan generic drug business was first choice", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "BRIEF-Teva says Allergan generic drug business was first choice | Reuters", "spam_score": 0.0, "site_type": "news", "published": "2015-07-27T16:58:00.000+03:00", "replies_count": 0, "uuid": "f9c0cf4336962770c882bee05965ed1e8df796ad"}, "author": "Reuters", "url": "http://www.reuters.com/article/2015/07/27/idUSL5N1072L020150727", "ord_in_thread": 0, "title": "BRIEF-Teva says Allergan generic drug business was first choice", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "July 27 Teva comments on Allergan generic drug acquisition:\n* Teva CEO says Allergan's generic drug business was preferred target in 2014\n* Allergan last year was not willing to sell so Teva made bid for Mylan - Teva CEO\n* Teva approached Allergan again in last 2-1/2 weeks -Teva CEO\n* Allergan deal expected to result in fewer antitrust-related asset sales than Mylan deal would have\n* Teva says Allergan biosimilars were never on the table because it is joint venture with Amgen (Reporting by Tova Cohen and Steven Scheer )", "external_links": [], "published": "2015-07-27T16:58:00.000+03:00", "crawled": "2015-07-27T16:06:35.203+03:00", "highlightTitle": ""}